Time is of the essence when treating head injuries to avoid potentially serious complications, including disability or death, says the National Institute for Health and Care Excellence (NICE). Its updated guidance on the issue emphasises the importance of early detection and prompt treatment for both children and adults who have suffered trauma to the head.
Vitamin D status appears to be associated with reduced disease activity in patients with multiple sclerosis and a slower rate of disease progression, according to a study published online first in JAMA Neurology by Alberto Ascherio, Harvard School of Public Health, Boston, USA, and colleagues.
The presence of a gene variant in people with mild cognitive impairment is associated with accelerated rates of brain atrophy, according to a new study published online in the journal Radiology.
Results of an internal study of 40 worldwide Visius surgical theatre hospital customers indicates that nearly 13,000 patients have been treated using intraoperative MRI (iMRI) since the first installation in 2005
Stryker and NeuroLogica have announced an exclusive partnership agreement in which Stryker will promote and sell NeuroLogica’s BodyTom portable full-body computed tomography (CT) scanner for the specialties of neurosurgery, spine surgery, orthopaedic surgery, and trauma surgery in conjunction with the Stryker NAV3i surgical navigation platform
A study from Australia, published online first in BMC Psychology, has confirmed the effectiveness a new test for Alzheimer’s disease. The test is said to detect cognitive decline in patients by scoring attention/reaction and learning/memory and comparing the scores to traditional cognitive impairment indicators
University Medical Center Hamburg-Eppendorf, Germany, is now offering the use of the EBS Next Wave brain stimulation device designed to expand the visual field of patients with impaired vision caused by optic nerve damage, it was announced by EBS Technologies.
The Society of NeuroInterventional Surgery (SNIS) on 9 January has launched a 2014 national tour that will bring together physicians and medical personnel across the USA involved in stroke care to address current stroke treatment and the value of neurointerventional therapy in optimal stroke care delivery.
The first patient was treated in the phase I/II NSI-566 stem cell trial to treat motor deficits from ischaemic stroke at BaYi Brain Hospital in Beijing, China, according to a press release.
In patients treated with carotid artery stenting, periprocedural haemodynamic depression is associated with an excess of new ischaemic lesions on diffusion-weighted imaging, the randomised International Carotid Stenting Study (ICSS)-MRI substudy has concluded. The findings were published in the January 2014 issue of Stroke.
Reverse Medical has announced receiving CE mark approval for the Barrel vascular reconstruction device and its first use in a European clinical case. The Barrel vascular reconstruction device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
Sequent Medical, Inc. announced today the presentation of long-term results from a retrospective study of the WEB™ Aneurysm Embolization System at the World Federation of Interventional Neuroradiology (WFITN) Congress.
La SEOM inició en febrero de 2013 una campaña de comunicación bajo el lema: EN ONCOLOGÍA, CADA AVANCE SE ESCRIBE CON MAYÚSCULAS. Mensualmente la Sociedad está emitiendo notas de prensa con la evolución y los avances que han supuesto los principales tumores. Para el mes de diciembre, destacamos los avances más importantes en los Tumores del Sistema Nervioso Central (SNC).
Sequent Medical, Inc. (Aliso Viejo, CA) announced the presentation of long-term results from a retrospective study of the company’s Web aneurysm embolization system at the World Federation of Interventional Neuroradiology Congress in Buenos Aires, Argentina. The data were presented by Professor Laurent Pierot, MD, who is Head of the Department of Radiology at Maison Blanche Hospital in Reims, France.
Un 63,5% de la población no es capaz de identificar ningún síntoma de ictus y menos de un 50% llamaría a los servicios de emergencias o acudiría al hospital
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos